Navigation Links
Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting
Date:5/21/2010

CALGARY, May 21 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that abstracts covering clinical research with reovirus (REOLYSIN(R)) are available on the American Society of Clinical Oncology (ASCO) website at www.asco.org, and on the Oncolytics website at www.oncolyticsbiotech.com. The research is scheduled to be presented at the ASCO 2010 Annual Meeting in Chicago, IL, June 4-8, 2010.

The first abstract entitled "A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck (SCCHN)," covers a poster presentation of updated results from the REO 011 study. The researchers reported that thirty-one patients (24 males; median age 59 years) with head and neck cancer (n=24), melanoma (n=4), peritoneal/endometrial cancer (n=2), or sarcoma (n=1) received 147 cycles (median 5, range 1-8) of treatment. In the dose-escalation phase of the study, there were no dose-limiting toxicities. Grade 3/4 toxicities included anaemia, leucopenia, neutropenia, lymphopenia, thrombocytopenia, infection and hypotension. Neutralising antireovirus antibody responses will be presented. In the Phase 1 study, partial responses (PR
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study
2. Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
3. Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results
4. Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
5. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
6. Oncolytics Biotech(R) Inc. Receives Approval from the U.K. MHRA to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
7. Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
8. Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters Over-Allotment Option
9. Oncolytics Biotech(R) Inc. Announces Unit Offering
10. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting
11. Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Oven Industries Inc. announces a new laboratory ... controller has many outstanding user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... be used universally, which allows the user to use ...
(Date:5/20/2013)... , May 20, 2013  MiMedx Group, Inc. ... and marketer of patent protected regenerative biomaterials and bioimplants ... has secured a revolving line of credit with Bank ... is secured by the Company,s accounts receivable and inventory, ... May 1, 2014.  The facility will be used for ...
(Date:5/20/2013)... -- Today, at the American Psychiatric Association (APA) Meeting ... James McGough , M.D., M.S., principal investigator and ... Neuroscience and Human Behavior and David Geffen ... California Los Angeles (UCLA), and director of clinical teaching ... at UCLA, presented the results of a Phase I ...
(Date:5/20/2013)... 2013  (PSHR) Pacific Shore Holdings, Inc. a ... a broad range of product categories lines, today ... firm, BlueWater Advisory Group, to provide strategic counsel ... and to direct the company,s outreach and investor ... Matthew Mills , Pacific Shore Holdings, ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Shore Holdings Retains Investor Relations Firm 2
... good workers to Procter & Gambles manufacturing plant in Green ... and technology used by those workers is another matter. , ... Bounty and Puffs have increased 50 percent, with no machine ... companys Green Bay plant. The last time anybody built a ...
... Wis. -- The Congenital Heart Institute at ... are now utilizing VERICIS Cardiovascular Information System. VERCIS, developed ... images and is designed to improve patient care. , ... hospitals echocardiography labs, giving physicians network access to cardio ...
... Wisconsins biotechnology sector and other well-established biotech regions is ... News featuring Wisconsins biotech sector as Americas Third ... , ,The East and West Coasts are often regarded ... flourish, some believe Wisconsin is catching up. According to ...
Cached Biology Technology:To attract investment, convince manufacturers that regulatory reform is real 2To attract investment, convince manufacturers that regulatory reform is real 3Wisconsin's biotech industry recognized by national publication 2
(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
(Date:5/20/2013)... the effect of physical education (PE) on child weight, ... increasing the amount of time that elementary schoolchildren spent ... The study represents some of the first evidence of ... is forthcoming in the Journal of Health Economics ... can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The ...
(Date:5/20/2013)... lungs of the planet, inhales carbon dioxide as it exudes ... parts that eventually fall to the ground to decompose or ... Until recently people believed much of the rain forest,s carbon ... the ocean. University of Washington research showed a decade ago ... left open the question of how that was possible, since ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2Gym class reduces probability of obesity, study finds for first time 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
... -Philadelphia, Pa Two internationally recognized scientists with strong Philadelphia ... The award ceremony will be held at 5:30 p.m. on ... College of Physicians of Philadelphia, located at 19 South 22nd ... a Scottish chemist and philanthropist who had a love of ...
... craters they leave behind , F. Pacheco-Vazquez and J.C. ... It,s generally accepted that craters in the moons and ... some craters completely flat while others show central peaks? ... material appear to provide a solution to the long-standing ...
... informatics professionals, honors four leaders in biomedical and ... during AMIA,s Annual Symposium, Oct. 22-26, an event ... Washington Hilton over the coming week. The Signature ... the health sector have had significant, positive impact. ...
Cached Biology News:Philadelphia scientists to be honored with the John Scott Award 2Philadelphia scientists to be honored with the John Scott Award 3Crater shapes explained, how carnivorous plants bite, and doubts about faster-than-light neutrinos 2AMIA honors informatics professionals who are improving health, changing the world 2AMIA honors informatics professionals who are improving health, changing the world 3
GFX PCR DNA,Gel Band Purif,100, 1 EA. Category: Nucleotide Sample Handling....
... Services are uniquely positioned to ... current competitive environment. Invitrogens experts ... express, purify, and characterize proteins ... Studies, Activity Assays, X-ray Crystallography, ...
Protein 3D structure prediction, via threading. Easy to use....
... Tray (3 per pack), 1. ... blot processing.Automated staining of Coomassie Blue ... nucleic acid analysis.Prepares blots for high ... control of protocol, solution, volume, and ...
Biology Products: